The Delhi High Court has ordered Patanjali to immediately take down its controversial advertisement that allegedly defamed rival chyawanprash brands as “dhoka.” The court directed removal from all media platforms, including TV, OTT, print, and social media.
Today, On 3rd July, The Delhi High Court has directed Patanjali to take down advertisements that allegedly disparage Dabur’s Chyawanprash. This interim order came in response to a suit filed by Dabur accusing Patanjali of misleading and negative advertising.
Today, On 26th March, The Supreme Court has ordered all states and union territories to create a system to handle complaints about misleading advertisements. The court stressed that such ads “can cause great harm to society” and must be strictly regulated. A bench of Justices Abhay S. Oka and Ujjal Bhuyan said the public should have a way to report ads violating the Drugs and Magic Remedies Act, 1954.
Kerala: Today, 6th Feb, Baba Ramdev and Acharya Balkrishna, the promoters of Patanjali Ayurved, have filed an application in a Kerala court, requesting the recall of a non-bailable arrest warrant that was issued against them for not attending a scheduled court hearing in a case related to misleading advertisements.
A Kerala court has issued a bailable arrest warrant against Baba Ramdev and Acharya Balakrishna after allegations of misleading claims about Patanjali Ayurved products curing ailments like diabetes and high blood pressure. The case, triggered by complaints from ophthalmologist K.V. Babu, cites violations of the Drugs and Magic Remedies Act. This action follows the Supreme Court’s warning against unchecked misleading advertisements.
Today, On 15th January, The Supreme Court closed the contempt case against Dr. RV Asokan, President of the Indian Medical Association (IMA), for making contemptuous remarks about the court. These comments were made during a press interview while the IMA’s plea against Patanjali Ayurved, regarding misleading advertisements, was still pending. The court found no reason to proceed further with the case. Dr. Asokan had criticized the court’s actions in the ongoing legal matter.
Dabur has filed a lawsuit against Patanjali Ayurved in the Delhi High Court Tuesday (24th Dec),, alleging that Patanjali aired misleading advertisements claiming its Chyawanprash is the “original” product. Dabur seeks to restrain these ads, arguing they harm its business and mislead consumers. The case is scheduled for a hearing in January.
A Division Bench of the Bombay High Court stayed a single-judge’s decision to impose a Rs 4.5 crore penalty on Patanjali Ayurved in a trademark infringement case. The costs were levied on Patanjali by a single Bench of Justice RI Chagla in July this year for violating an interim order that prohibited the company from selling camphor products that allegedly infringed on the trademark of Mangalam Organics. Justices AS Chandurkar and Rajesh Patil today stayed the single-judge orders of July 8 and July 29, but allowed the Rs 50 lakhs already deposited by Patanjali to remain with the Court.
The Supreme Court Today (Aug 27) said the Indian Medical Association president R V Asokan’s unconditional apology published in a newspaper over his “damaging” statements in an interview to PTI was illegible and the font miniscule.
Today(13th August), the Supreme Court closed the contempt case against yoga guru Baba Ramdev and Acharya Balakrishna after they agreed to cease issuing misleading advertisements and claims about Patanjali Ayurved products.
